Suzette Delaloge

ScholarGPS® ID: 67779301200062

Highly Ranked Scholar - Prior Five Years:

#11

Metastatic breast cancer

Affiliation

Institut Gustave Roussy, France

Affiliation History

Field

Medicine

Discipline

Oncology

Top Specialties

Metrics Summary

Publication Count

519

Predicted Citations

26,169

Predicted h-index

Ranking

Publications and Citation History

Publications based on Top Specialties

Types of Publication

Publications
Books
Patents
NIH/NSF

Add Delete
Randomized Phase III Study of Amcenestrant Plus Palbociclib Versus Letrozole Plus Palbociclib in Estrogen Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer: Primary Results From AMEERA-5 (journal article) Cortés, Javier \| Hurvitz, Sara A. \| O'Shaughnessy, Joyce \| Delaloge, Suzette \| Iwata, Hiroji \| Rugo, Hope S. \| Neven, Patrick \| Kanagavel, Dheepak \| Cohen, Patrick \| Paux, Gautier \| ... \| Bardia, Aditya Journal of Clinical Oncology (2024). 10.1200/JCO.23.02036 Cite \| Source
Breast cancer survivors’ opinion on personalizing endocrine therapy and developing informative tools (journal article) Rassy, Elie \| Benvenuti, Chiara \| Akla, Sarra \| Di Meglio, Antonio \| Martin, Elise \| Havas, Julie \| Rieutord, André \| Combarel, David \| Fasse, Léonor \| Scotté, Florian \| ... \| Pistilli, Barbara npj Breast Cancer, volume 10, issue 1 (2024). 10.1038/s41523-024-00655-1 Cite \| Source
Information and prevention needs among germline TP53 (g TP53 m)pathogenic variants carriers. (journal article) Ben Ahmed, Tarek \| Vidican, Pauline \| Corradini, Nadège \| Lasset, Christine \| Goldbarg, Veronica \| Guerrini-Rousseau, Léa \| Claret, Beatrivr \| Fervers, Béatrice \| Rochefort, Pauline \| Delaloge, Suzette \| Caron, Olivier Journal of Clinical Oncology, volume 42, issue 16_suppl, pages 10551-10551 (2024). 10.1200/JCO.2024.42.16_suppl.10551 Cite \| Source
Real-world evidence reported for clinical efficacy evaluation in European Public Assessment Reports of authorised targeted therapies for solid malignancies: a comprehensive review (2018-2022) (journal article) Derksen, J.W.G. \| Martins-Branco, D. \| Valachis, A. \| Pellat, A. \| van Nassau, S.C.M.W. \| Aggarwal, A. \| Pentheroudakis, G. \| Koopman, M. \| Castelo-Branco, L. \| Delaloge, S. ESMO Real World Data and Digital Oncology, volume 4 (2024). 10.1016/j.esmorw.2024.100039 Cite \| Source
Real-world effectiveness of post-trastuzumab emtansine treatment for human epidermal growth factor receptor 2-positive metastatic breast cancer: a multicenter, matched cohort analysis from the Epidemiology Strategy and Medical Economics database (2008-201 (journal article) Courtinard, C. \| Barbet, V. \| Schiappa, R. \| Pilleul, F. \| Michiels, S. \| Dabakuyo, S. \| Gourgou, S. \| Jaffre, A. \| Asselain, B. \| Bosquet, L. \| ... \| Delaloge, S. ESMO Real World Data and Digital Oncology, volume 4 (2024). 10.1016/j.esmorw.2024.100043 Cite \| Source
4MO Neoadjuvant letrozole and palbociclib versus chemotherapy in the NeoPAL study: A translational analysis (journal article) Cottu, P.H. \| Kieffer, Y. \| Lemonnier, J. \| D'Hondt, V. \| Duhoux, F.P. \| Callens, C. \| Gentien, D. \| Desmoulins, I. \| Mouret-Reynier, M-A. \| Levy, C. \| ... \| Vincent-Salomon, A. ESMO Open, volume 9 (2024). 10.1016/j.esmoop.2024.103014 Cite \| Source
237P Overall survival (OS) estimation using target trial emulation of major randomized controlled trials (RCTs) with the ESME metastatic breast cancer (MBC) real-world data (RWD) (journal article) Antoine, A. \| Perol, D. \| Robain, M. \| Bachelot, T. \| Choquet, R. \| Jacot, W. \| Ben Hadj Yahia, B. \| Grinda, T. \| Delaloge, S. \| Lasset, C. \| Drouet, Y. ESMO Open, volume 9 (2024). 10.1016/j.esmoop.2024.103258 Cite \| Source
171P A deep learning model for breast cancer diagnosis from fine-needle aspiration cytology whole slide images (journal article) Le Bescond, L. \| Suciu, V. \| Christodoulidis, S. \| Vakalopoulou, M. \| Talbot, H.G. \| Soufan, R. \| Balleyguier, C. \| Delaloge, S. \| André, F. ESMO Open, volume 9 (2024). 10.1016/j.esmoop.2024.103193 Cite \| Source
142P Exploring 18F-FDG PET as a predictior of immune-related adverse events (irAEs) in early-stage triple-negative breast cancer (eTNBC) (journal article) Daverio, A.L. \| Giugliano, F. \| Douglas, J.R. Dixon \| Rached, L.W. \| Laparra, A. \| Sakkal, M. \| Bousrih, C. \| Viansone, A.A. \| Delaloge, S. \| Pistilli, B. \| ... \| Henry, T. ESMO Open, volume 9 (2024). 10.1016/j.esmoop.2024.103129 Cite \| Source
73P Real-world analysis of the use of the 21-gene assay in prognostically intermediate luminal breast cancer (BC): Experience from a French multicenter cohort (journal article) Cutuli, B. \| Joyon, N. \| De Poncheville, L. \| Lacroix-Triki, M. \| Delaloge, S. \| Mourato, J.T.L. Ribeiro \| Bousrih, C. \| Viansone, A.A. \| Charles, C. ESMO Open, volume 9 (2024). 10.1016/j.esmoop.2024.103079 Cite \| Source
Locoregional Breast Cancer Recurrence in the European Organisation for Research and Treatment of Cancer 10041/BIG 03-04 MINDACT Trial: Analysis of Risk Factors Including the 70-Gene Signature (journal article) Alaeikhanehshir, Sena \| Ajayi, Taiwo \| Duijnhoven, Frederieke H. \| Poncet, Coralie \| Olaniran, Ridwan O. \| Lips, Esther H. \| van 't Veer, Laura J. \| Delaloge, Suzette \| Rubio, Isabel T. \| Thompson, Alastair M. \| ... \| Rutgers, Emiel J.T. Journal of Clinical Oncology, volume 42, issue 10, pages 1124-1134 (2024). 10.1200/JCO.22.02690 Cited by (2) \| Cite \| Source
Evaluation of the satisfaction and experiences of oncology patients and doctors using teleconsultation during the COVID-19 pandemic (journal article) Kastrisiou, Myrto \| Karimi, Maryam \| Christou, Evangelos AA \| Bizot, Alexandra \| Ropers, Marie-Alix \| De-Jesus, Anne \| Mokdad-Adi, Meriem \| To, Thi Hong Van \| Viansone, Alessandro \| Delaloge, Suzette \| ... \| Kfoury, Maria Journal of Telemedicine and Telecare (2024). 10.1177/1357633X241229462 Cited by (1) \| Cite \| Source
Rs867228 in FPR1 accelerates the manifestation of luminal B breast cancer (journal article) Carbonnier, Vincent \| Le Naour, Julie \| Bachelot, Thomas \| Vacchelli, Erika \| André, Fabrice \| Delaloge, Suzette \| Kroemer, Guido OncoImmunology, volume 12, issue 1 (2023). 10.1080/2162402X.2023.2189823 Cited by (5) \| Cite \| Source
Insights adjusting for non-adherence in randomized clinical trials: a reanalysis of an adjuvant trial of tamoxifen duration in early breast cancer (journal article) Giudici, Fabiola \| Pistilli, Barbara \| Vaz-Luis, Ines \| Karimi, Maryam \| Delaloge, Suzette \| Bachelot, Thomas \| Michiels, Stefan \| Bardet, Aurelie British Journal of Cancer, volume 129, issue 9, pages 1516-1523 (2023). 10.1038/s41416-023-02420-w Cite \| Source
Real-World Diagnostic Accuracy of the On-Site Cytopathology Advance Report (OSCAR) Procedure Performed in a Multidisciplinary One-Stop Breast Clinic (journal article) Suciu, Voichita \| El Chamieh, Carolla \| Soufan, Ranya \| Mathieu, Marie-Christine \| Balleyguier, Corinne \| Delaloge, Suzette \| Balogh, Zsofia \| Scoazec, Jean-Yves \| Chevret, Sylvie \| Vielh, Philippe Cancers, volume 15, issue 20, pages 4967- (2023). 10.3390/cancers15204967 Cited by (3) \| Cite \| Source
1702P Real-world evidence contributions to European medicines agency’s safety and efficacy evaluations of oncology targeted therapies between 2018-2022 (journal article) Derksen, J.W.G. \| Martins Branco, D. \| Pellat, A. \| van Nassau, S.C.M.W. \| Valachis, A. \| Aggarwal, A. \| Koopman, M. \| Pentheroudakis, G. \| Castelo-Branco, L. \| Delaloge, S. Annals of Oncology, volume 34 (2023). 10.1016/j.annonc.2023.09.2656 Cited by (1) \| Cite \| Source
1689O Comprehensive mapping review of real-world evidence publications focusing on targeted therapies in solid tumors: A collaborative work from ESMO real-world data and Digital Health Working Group (journal article) Pellat, A. \| Grinda, T. \| Prelaj, A. \| Cresta, P. \| Valachis, A. \| Zerdes, I. \| Martins Branco, D. \| Provenzano, L. \| Spagnoletti, A. \| Nader Marta, G. \| ... \| Koopman, M. Annals of Oncology, volume 34 (2023). 10.1016/j.annonc.2023.09.2643 Cited by (4) \| Cite \| Source
AMEERA-3: Randomized Phase II Study of Amcenestrant (Oral Selective Estrogen Receptor Degrader) Versus Standard Endocrine Monotherapy in Estrogen Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer (journal article) Tolaney, Sara M. \| Chan, Arlene \| Petrakova, Katarina \| Delaloge, Suzette \| Campone, Mario \| Iwata, Hiroji \| Peddi, Parvin F. \| Kaufman, Peter A. \| De Kermadec, Elisabeth \| Liu, Qianying \| ... \| Im, Seock-Ah Journal of Clinical Oncology, volume 41, issue 24, pages 4014-4024 (2023). 10.1200/JCO.22.02746 Cited by (22) \| Cite \| Source
Olaparib efficacy in patients with germline BRCA ‐mutated, HER2 ‐negative metastatic breast cancer: Subgroup analyses from the phase III OlympiAD trial (journal article) Senkus, Elżbieta \| Delaloge, Suzette \| Domchek, Susan M. \| Conte, Pierfranco \| Im, Seock‐Ah \| Xu, Binghe \| Armstrong, Anne \| Masuda, Norikazu \| Fielding, Anitra \| Robson, Mark \| Tung, Nadine International Journal of Cancer, volume 153, issue 4, pages 803-814 (2023). 10.1002/ijc.34525 Cited by (9) \| Cite \| Source
Target trial emulation to assess real-world efficacy in the Epidemiological Strategy and Medical Economics metastatic breast cancer cohort (journal article) Antoine, Alison \| Pérol, David \| Robain, Mathieu \| Delaloge, Suzette \| Lasset, Christine \| Drouet, Youenn JNCI: Journal of the National Cancer Institute, volume 115, issue 8, pages 971-980 (2023). 10.1093/jnci/djad092 Cited by (1) \| Cite \| Source